Tom Schrader
Analyst
VTIG
Equibles does not estimate personal net worth.
About Tom Schrader
Tom Schrader is recorded as Analyst at VTIG. Tom Schrader has spoken on 1 earnings call across 1 company, most recently for NRX Pharmaceuticals, Inc. on August 17, 2026. The companies whose calls Tom Schrader spoke on are classified in the Healthcare sector.
Tom Schrader on recent calls
“So I really just have one sort of big picture call or question. How do you think about launching Ketafree when you have the NDA ketamine coming on its tail? Well, and I guess my view is that's a very different drug because of its likely potential for reimbursement, but it's really the same drug.”
Affiliation history
-
VTIG
Analyst
Transcript header (unverified)
Current